FFAR1 and type 2 diabetes mellitus: This mechanism seems to be impaired under type 2 diabetes conditions, as glucose-mediated 20-HETE production was decreased and both a 20-HETE formation blockade as well as FFAR1 antagonists were largely ineffective in blocking GSIS under type 2 diabetes [47].